Bio Essence Corp (BIOE)

Price$0.1900Cached quote
BIOEOTC
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

6 annual periodsNewest to oldest
202520242023202220212020
Revenue$1.9M$323,940$551,506$621,590$887,984$958,700
Gross profit$1.4M$217,077$277,446$328,326$298,324$227,287
Gross margin75.28%67.01%50.31%52.82%33.60%23.71%
Operating expenses$528,402$676,515$345,590$839,464$1.2M$1.1M
Operating income$900,011−$459,438−$345,590−$511,138−$857,527−$832,566
Operating margin47.43%−141.83%−62.66%−82.23%−96.57%−86.84%
EBITDA$900,246−$458,527−$340,797−$496,625−$821,725−$799,286
EBITDA margin47.44%−141.55%−61.79%−79.90%−92.54%−83.37%
Net income$896,197−$1.3M−$971,879−$809,679−$647,564−$595,838
Net profit margin47.23%−404.02%−176.22%−130.26%−72.93%−62.15%
Basic EPSper basic share$0.02-$0.03-$0.03-$0.02-$0.02-$0.02
Diluted EPSper diluted share$0.02-$0.03-$0.03-$0.02-$0.02-$0.02

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 1 reported holders of BIOE
HolderShares held
Yan Yin
—

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys1$2.50M disclosed value
Sells (SEC code S)13$2.98M disclosed value
14 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Oct 30, 2024Form 4Yan YinChief Executive OfficerSellCommon Stock143.8K$0.57$82.0K82.1K
Oct 29, 2024Form 4Yan YinChief Executive OfficerSellCommon Stock40.0K$0.64$25.6K2.6K
Oct 28, 2024Form 4Yan YinChief Executive OfficerSellCommon Stock140.0K$2.48$347.2K345.9K
Sep 30, 2024Form 4Yan YinChief Executive OfficerSellCommon stock2.0K$2.35$4.7K13.68M
Sep 27, 2024Form 4Yan YinChief Executive OfficerSellCommon Stock200$1.69$338.0013.69M

Community posts

It’s quiet here.

No posts about BIOE yet. Start the conversation.

Write the first post